LipoScience (LPDX +3.4%) trades up today after announcing the availability of its NMR...

|About: LipoScience (LPDX)|By:, SA News Editor

LipoScience (LPDX +3.4%) trades up today after announcing the availability of its NMR lipoprotein particle testing using the Vantera Clinical Analyzer through Mayo Medical Laboratories. The analysis provides physicians and patients with a detailed assessment of cardiovascular disease risk from a single blood test that measures the concentration of low-density lipoprotein particles and other lipoprotein information.